MilliporeSigma Awarded Second U.S. Patent for CRISPR Gene-Editing Technology
Go back to MilliporeSigma Awarded Second U.S. Patent for CRISPR Gene-Editing Technology| (AMEX: MKKGY) | Delayed: 31.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.61 | 52 Week High | $ | |||
| Open | $31.61 | 52 Week Low | $ | |||
| Day High | $31.61 | P/E | N/A | |||
| Day Low | $31.61 | EPS | $ | |||
| Volume | 1 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 127.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $127.63 | 52 Week High | $65.46 | |||
| Open | $127.63 | 52 Week Low | $47.97 | |||
| Day High | $127.63 | P/E | 86.82 | |||
| Day Low | $127.63 | EPS | $1.47 | |||
| Volume | 40,602 | |||||
